Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-03

Clinical Trial Update: Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Tisporin Eye Drops to Restasis Eye Drops after treatment to evaluate efficacy and safety in moderate-to-severe dry eye disease has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Restasis Eye Drops (cyclosporine ophthalmic emulsion)
  • Tisporin Eye Drops

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED